CH

CHEIL BIO CO., LTD.

Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.

052670 | KO

Overview

Corporate Details

ISIN(s):
KR7052670007
LEI:
Country:
South Korea
Address:
경기 안산시 목내동 456-2, 안산시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cheil Bio Co., Ltd. is a manufacturer of animal medicines and veterinary products focused on improving the health of livestock, aquatic animals, and pets. The company develops, produces, and distributes a wide range of pharmaceuticals, including antibiotics, nutritional supplements, probiotics, and functional feed additives. Leveraging its research and development capabilities, Cheil Bio aims to provide high-quality, technologically advanced solutions for the poultry, swine, cattle, and fishery sectors. The company is committed to achieving global technological competitiveness through continuous innovation in biotechnology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Share Issue/Capital Change
[기재정정]액면주식ㆍ무액면주식전환결정
Korean 16.9 KB
2025-09-15 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 31.6 KB
2025-09-10 00:00
Legal Proceedings Report
주요사항보고서(소송등의제기)
Korean 5.7 KB
2025-08-26 00:00
Delisting Announcement
주권매매거래정지기간변경 (주식의 병합, 분할 등 전자등록 변경, 말소)
Korean 4.9 KB
2025-08-26 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 8.4 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.0 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 780.5 KB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 14.1 KB
2025-08-01 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 14.4 KB
2025-08-01 00:00
Share Issue/Capital Change
[기재정정]액면주식ㆍ무액면주식전환결정
Korean 15.4 KB
2025-08-01 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 35.6 KB
2025-07-21 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.9 KB
2025-07-18 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 9.6 KB
2025-07-18 00:00
Share Issue/Capital Change
액면주식ㆍ무액면주식전환결정
Korean 10.6 KB
2025-07-18 00:00
Share Issue/Capital Change
주요사항보고서(감자결정)
Korean 24.7 KB

Automate Your Workflow. Get a real-time feed of all CHEIL BIO CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHEIL BIO CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHEIL BIO CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.